Markets rebounded from lows despite a down week. Earnings reports drove movement, with Apple rising. Tariff concerns grow as ...
Yes, Apple missed big in Greater China, but Evercore ISI analyst Amit Daryanani said the company has "plenty of offsets" to the pressure there. He called out Apple's "ability to manage China headwinds ...
We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...
Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...
In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against the other stocks recommended by Cliff Asness. The founder, managing principal, and chief investment ...
Devin Smith, from Massillon, caught a 45-yard pass from Clevelander Cardale Jones. Joey Bosa, from Florida, led the assault on Marcus Mariota, who threw into a secondary including Eli Apple ...
Apple Intelligence is the Cupertino company's name for the AI that now sits at the beating heart of its operating systems on iPhone, iPad and Mac. But rather than being released in one go ...
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain ...
we're rounding up the best Apple deals in one spot. From Mac laptops to Apple iPads, here are the best Apple deals you can score right now. Also, make sure to check out our guide to the best Apple ...
Mac Jones was able to find joy again this season. That’s something he credits to former head coach Doug Pederson. “I feel like I got the joy of playing football again, just in OTAs ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...